CG Oncology, Inc. Common stock (CGON) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -56.94M | -36.22M | -38.89M | -27.96M | -29.28M | -20.66M | -15.92M | -16.12M | -26.01M | -16.06M | -10.85M | -7.99M | -6.83M |
| Operating CF Margin % | -5257.89% | -1559.69% | -2334.57% | - | -56301.92% | -4531.14% | -37020.93% | -14522.52% | -4917.2% | -1606100% | -120511.11% | -4116.49% | - |
| Operating CF Growth % | -94.5% | -75.28% | -144.32% | -73.44% | -12.55% | -28.65% | -46.77% | - | -225.72% | -135.19% | - | - | - |
| Net Income | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.55M | -11.77M | -8.67M | -8.39M |
| Depreciation & Amortization | 841K | 849K | 416K | 156K | 24K | 0 | 21K | 7K | 4K | -5K | 5K | 4K | 4K |
| Stock-Based Compensation | 0 | 7.19M | 7.33M | 7.01M | 5.15M | 4.99M | 2.65M | 2.25M | 1.52M | 778K | 394K | 179K | 148K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 8.2M | 1.04M | 40K | -2.36M | -469K | 1.25M | -1.59M | -2.48M | -2.2M | -2.44M | 328K | 125K | 107K |
| Working Capital Changes | -5.78M | -3.98M | -2.87M | 8.66M | 469K | 4.9M | 3.4M | 3.01M | -8.4M | 2.16M | 195K | 373K | 1.3M |
| Change in Receivables | -587K | -301K | -238K | -217K | 436K | -644K | 45K | 0 | 0 | 0 | -1K | 0 | 0 |
| Change in Inventory | 72K | -64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.52M | -3.48M | 1.23M | 394K | 214K | 2.44M | -415K | -168K | 1.42M | 1.38M | 590K | -9K | 186K |
| Cash from Investing | -334.85M | -75.5M | 15.04M | 1.41M | -186.77M | 10.9M | 32.01M | -36.23M | -307.44M | 16.94M | -162.8M | -78.7M | -55.34M |
| Capital Expenditures | -304K | -7K | -97K | -14K | -16K | -209K | 1K | -14K | -12K | 0 | 6K | 0 | 1K |
| CapEx % of Revenue | 28.07% | 0.3% | 5.82% | - | 30.77% | 45.83% | 2.33% | 12.61% | 2.27% | - | 66.67% | - | - |
| Acquisitions | 0 | 0 | -21.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 26M | -1M | -25M | 0 | 0 | 0 | 0 | 396.42M | -1.41M | 0 | 0 |
| Cash from Financing | 393M | 99.07M | 54.37M | -296K | 450K | 223.41M | 2.17M | 40K | 402.66M | -2.89M | 105.88M | -765K | 56.7M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 365K | 0 | 0 | -365K | -1K | -67K | -833K | 0 |
| Equity Issued (Net) | 393.17M | 99.07M | 49M | -296K | 450K | 223.41M | 2.17M | 40K | 406.41M | 2K | 0 | 0 | 56.7M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -174K | 0 | 5.37M | 0 | 0 | -365K | 0 | 0 | -3.39M | -2.89M | 105.94M | 68K | 0 |
| Net Change in Cash | 1.21M | -12.65M | 30.52M | -26.85M | -215.6M | 213.66M | 18.25M | -52.31M | 69.2M | -2.01M | -67.77M | -87.45M | -5.47M |
| Free Cash Flow | -57.25M | -36.22M | -38.99M | -27.97M | -29.29M | -20.87M | -15.92M | -16.13M | -26.02M | -16.06M | -10.84M | -7.99M | -6.83M |
| FCF Margin % | -5285.96% | -1559.99% | -2340.4% | - | -56332.69% | -4576.97% | -37018.6% | -14535.14% | -4919.47% | -1606100% | -120444.44% | -4116.49% | - |
| FCF Growth % | -95.43% | -73.56% | -144.95% | -73.38% | -12.56% | -29.95% | -46.84% | - | -225.87% | -135.22% | - | - | - |
| FCF per Share | -0.68 | -0.47 | -0.51 | -0.37 | -0.38 | -0.32 | -0.24 | -0.24 | -0.39 | -0.24 | -0.16 | -0.12 | -0.10 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.88x | 0.89x | 0.67x | 0.85x | 0.65x | 0.78x | 0.85x | 1.54x | 1.00x | 0.92x | 0.92x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 271K | 287K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40K | 40K | 0 | -28K |